Australia markets closed

Cabaletta Bio, Inc. (CABA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
11.81-0.38 (-3.12%)
At close: 04:00PM EDT
11.56 -0.25 (-2.12%)
After hours: 05:23PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 570.15M
Enterprise value 354.47M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)2.57
Enterprise value/revenue N/A
Enterprise value/EBITDA -3.44

Trading information

Stock price history

Beta (5Y monthly) 2.52
52-week change 325.37%
S&P500 52-week change 327.84%
52-week high 326.35
52-week low 39.02
50-day moving average 314.84
200-day moving average 317.21

Share statistics

Avg vol (3-month) 31.16M
Avg vol (10-day) 3822.11k
Shares outstanding 548.28M
Implied shares outstanding 648.28M
Float 843.45M
% held by insiders 13.14%
% held by institutions 1107.28%
Shares short (30 Apr 2024) 410.25M
Short ratio (30 Apr 2024) 47.72
Short % of float (30 Apr 2024) 421.95%
Short % of shares outstanding (30 Apr 2024) 421.24%
Shares short (prior month 28 Mar 2024) 48.5M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-31.16%
Return on equity (ttm)-49.06%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -84.28M
Net income avi to common (ttm)-76.87M
Diluted EPS (ttm)-1.71
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)223.84M
Total cash per share (mrq)4.64
Total debt (mrq)8.17M
Total debt/equity (mrq)3.68%
Current ratio (mrq)12.66
Book value per share (mrq)4.59

Cash flow statement

Operating cash flow (ttm)-64.93M
Levered free cash flow (ttm)-38.9M